Key result
Oral pazopanib administration produced a significant clinical response in a patient with angiosarcoma of the scalp.
Why the study?
Does oral pazopanib improve outcomes in a patient with angiosarcoma of the scalp?
Does oral pazopanib improve outcomes in a patient with angiosarcoma of the scalp?
Oral pazopanib may be an effective treatment for angiosarcoma of the scalp, a condition with a poor prognosis and no standard treatment guidelines.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for pazopanib in scalp angiosarcoma; prospective trials needed before clinical adoption.
Tomita et al. (2013) studied this question. Oral pazopanib administration produced a significant clinical response in a patient with angiosarcoma of the scalp.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: